Holen Sie sich die Stockscreener-App
17.49
0.98%
0.17
Handel nachbörslich:
14.00
-3.49
-19.95%
Schlusskurs vom Vortag:
$17.32
Offen:
$17.52
24-Stunden-Volumen:
1.76M
Relative Volume:
1.18
Marktkapitalisierung:
$1.19B
Einnahmen:
$2.73B
Nettoeinkommen (Verlust:
$-1.13B
KGV:
-1.0497
EPS:
-16.6622
Netto-Cashflow:
$-83.00M
1W Leistung:
+14.16%
1M Leistung:
+2.28%
6M Leistung:
-35.96%
1J Leistung:
-34.15%
1-Tages-Spanne:
$17.26
$18.00
1-Wochen-Bereich:
$13.70
$18.00
52-Wochen-Spanne:
$13.70
$38.99
Quidelortho Corporation Stock (QDEL) Company Profile
Firmenname
Quidelortho Corporation
Sektor
Branche
Telefon
(858) 552-1100
Adresse
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Compare QDEL vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corporation
|
17.49 | 1.18B | 2.73B | -1.13B | -83.00M | -16.66 |
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Quidelortho Corporation Stock (QDEL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-07 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-05-08 | Hochstufung | Jefferies | Hold → Buy |
| 2024-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-12-10 | Eingeleitet | Jefferies | Hold |
| 2024-09-19 | Fortgesetzt | UBS | Neutral |
| 2024-09-05 | Hochstufung | Craig Hallum | Hold → Buy |
| 2024-03-04 | Herabstufung | UBS | Neutral → Sell |
| 2024-02-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-14 | Hochstufung | UBS | Sell → Neutral |
| 2022-09-19 | Eingeleitet | Citigroup | Neutral |
| 2022-07-20 | Eingeleitet | UBS | Sell |
| 2022-06-17 | Fortgesetzt | JP Morgan | Neutral |
| 2022-02-22 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-01-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-05-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-03-26 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2018-10-23 | Fortgesetzt | Raymond James | Strong Buy |
| 2018-03-08 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2018-01-22 | Bestätigt | Barclays | Overweight |
| 2018-01-04 | Hochstufung | CL King | Neutral → Buy |
| 2017-09-19 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2017-07-18 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2017-07-18 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2017-04-25 | Bestätigt | Canaccord Genuity | Hold |
| 2017-02-17 | Eingeleitet | CL King | Neutral |
| 2016-12-16 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2016-06-13 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2016-02-18 | Bestätigt | Barclays | Overweight |
| 2016-02-09 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2016-01-08 | Bestätigt | Canaccord Genuity | Buy |
| 2015-12-14 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-09-02 | Eingeleitet | Barclays | Overweight |
| 2013-07-31 | Bestätigt | Canaccord Genuity | Buy |
| 2011-03-03 | Herabstufung | Wedbush | Outperform → Neutral |
Alle ansehen
Quidelortho Corporation Aktie (QDEL) Neueste Nachrichten
QuidelOrtho (QDEL) Projects Lower Q1 2026 Revenue Amid Weaker De - GuruFocus
QuidelOrtho (QDEL) Sees 12% Drop Following Disappointing Q1 Reve - GuruFocus
QuidelOrtho announces preliminary revenue for the first quarter 2026 and provides update on full-year 2026 guidance - marketscreener.com
QuidelOrtho announces preliminary revenue for the first quarter of 2026 and updates its full-year 2026 performance outlook. - 富途牛牛
QuidelOrtho (QDEL) Projects Q1 2026 Revenue Impacted by Market C - GuruFocus
QuidelOrtho Expects Q1 Revenue of $615 Million-$620 Million; Shares Fall After Hours - marketscreener.com
QuidelOrtho stock plunges on weak revenue guidance By Investing.com - Investing.com Australia
QuidelOrtho reports preliminary Q1 2026 revenue of $615-620 million - StreetInsider
QuidelOrtho (NASDAQ: QDEL) guides Q1 revenue $615–620M with negative free cash flow - Stock Titan
Weaker flu season weighs on QuidelOrtho as Q1 sales fall below $620M - Stock Titan
QuidelOrtho Corp. Stock Plummets to New 52-Week Low at $14.00 - Markets Mojo
QuidelOrtho Corp. Hits Day Low at $14 Amid Price Pressure - Markets Mojo
QuidelOrtho Corp (QDEL) Shares Surge 7.7% -- What GF Score of 63 Tells Investors - GuruFocus
Volatility Watch: Is QuidelOrtho Corporation a defensive stockMarket Activity Summary & Precise Trade Entry Recommendations - baoquankhu1.vn
QuidelOrtho, Lifotronic Technology to Expand Global Immunoassay Portfolio - Medical Product Outsourcing
Today's Analyst Rating Update for QuidelOrtho (QDEL) | QDEL Stoc - GuruFocus
UBS cuts Quidel stock price target on weaker respiratory season By Investing.com - Investing.com India
UBS cuts Quidel stock price target on weaker respiratory season - Investing.com
UBS Adjusts Price Target on QuidelOrtho to $17 From $30, Maintains Neutral Rating - marketscreener.com
UBS Maintains QuidelOrtho(QDEL.US) With Hold Rating, Cuts Target Price to $17 - Moomoo
QuidelOrtho (QDEL) Is Down 18.0% After Proposed NIH Funding Cuts Raised Diagnostics Demand Questions - Sahm
Quidel Corporation stock hits 52-week low at 14.43 USD By Investing.com - Investing.com Australia
QuidelOrtho (QDEL) Is Down 7.6% After Proposed US Health Funding Cuts Raise Policy Uncertainty - Yahoo Finance
Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories stocks trade down, what you need to know - MSN
Assessing QuidelOrtho (QDEL) Valuation After Recent Share Price Volatility - Yahoo Finance
Weekly Earnings: Will QuidelOrtho Corporation benefit from rising consumer demandMarket Performance Report & Consistent Growth Equity Picks - baoquankhu1.vn
How does QuidelOrtho Corporation compare to its peers2026 Trading Recap & Long-Term Capital Growth Strategies - baoquankhu1.vn
Is It Time To Reassess QuidelOrtho (QDEL) After The Recent Share Price Slump? - simplywall.st
QuidelOrtho Corporation (QDEL) stock price, news, quote and history - Yahoo Finance UK
QuidelOrtho Corp (QDEL) Trading Down 5.04% on Apr 6 - GuruFocus
Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know - Yahoo Finance
QuidelOrtho (NASDAQ:QDEL) Shares Down 3.6%Should You Sell? - MarketBeat
QuidelOrtho Corporation (QDEL) Stock Price, News, Quote & History - Yahoo! Finance Canada
QuidelOrtho Corporation $QDEL Shares Sold by JPMorgan Chase & Co. - MarketBeat
QuidelOrtho (NASDAQ:QDEL) Rating Increased to Buy at Wall Street Zen - MarketBeat
Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell shares are falling, what you need to know - MSN
QuidelOrtho Corp Stock: Navigating Diagnostics Leadership Amid Sector Evolution and Investor Opportu - AD HOC NEWS
Aug Final Week: Is QuidelOrtho Corporation a defensive stock2026 Trading Volume Trends & Accurate Buy Signal Alerts - baoquankhu1.vn
Buyback Watch: Why is QuidelOrtho Corporation stock going downWeekly Trend Report & Real-Time Price Movement Reports - baoquankhu1.vn
QuidelOrtho Corporation (QDEL) Stock forecasts - Yahoo Finance UK
QuidelOrtho Corp. Stock Plummets to New 52-Week Low of $14.45 - Markets Mojo
Value Recap: Does QuidelOrtho Corporation offer margin of safetyMarket Growth Report & Verified Stock Trade Ideas - baoquankhu1.vn
QuidelOrtho Corp. Stock Plummets to New 52-Week Low of $17.08 - Markets Mojo
Precision Trading with Quidelortho Corp Com (QDEL) Risk Zones - Stock Traders Daily
Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know - Yahoo Finance
Vanguard disaggregates holdings; reports 0 shares of QuidelOrtho (QDEL) - Stock Titan
QuidelOrtho (NASDAQ:QDEL) Reaches New 12-Month LowHere's What Happened - MarketBeat
Why is QuidelOrtho (QDEL) down 24.5% since last earnings report? - MSN
QuidelOrtho Corporation (QDEL) Stock Forecasts - Yahoo Finance
QuidelOrtho Corporation (NASDAQ:QDEL) Given Average Recommendation of "Reduce" by Brokerages - MarketBeat
Medtech business QuidelOrtho hires STAAR Surgical legal head as CLO - The Global Legal Post
Finanzdaten der Quidelortho Corporation-Aktie (QDEL)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.40%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):